COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 142 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,491,192 | -33.9% | 66,720 | -36.5% | 0.00% | -33.3% |
| Q2 2023 | $2,257,417 | -35.6% | 105,045 | -28.1% | 0.00% | -40.0% |
| Q1 2023 | $3,507,170 | +132.6% | 146,193 | +125.0% | 0.01% | +150.0% |
| Q4 2022 | $1,507,513 | -99.8% | 64,979 | +8.3% | 0.00% | 0.0% |
| Q3 2022 | $961,504,000 | +38.2% | 60,019 | +52.9% | 0.00% | +100.0% |
| Q2 2022 | $695,687,000 | +180.1% | 39,260 | +221.8% | 0.00% | – |
| Q1 2022 | $248,372,000 | -15.2% | 12,199 | -22.2% | 0.00% | – |
| Q4 2021 | $292,884,000 | -56.5% | 15,679 | -54.0% | 0.00% | -100.0% |
| Q3 2021 | $672,759,000 | +131.8% | 34,081 | +177.6% | 0.00% | – |
| Q2 2021 | $290,276,000 | +84.8% | 12,279 | +85.3% | 0.00% | – |
| Q1 2021 | $157,036,000 | +11.6% | 6,626 | -5.7% | 0.00% | – |
| Q4 2020 | $140,751,000 | -14.3% | 7,027 | -11.0% | 0.00% | – |
| Q3 2020 | $164,311,000 | +660.9% | 7,892 | +539.5% | 0.00% | – |
| Q2 2020 | $21,595,000 | -86.8% | 1,234 | -87.7% | 0.00% | – |
| Q1 2020 | $163,218,000 | +108.4% | 9,995 | +162.6% | 0.00% | – |
| Q4 2019 | $78,327,000 | +42.2% | 3,806 | -20.7% | 0.00% | – |
| Q3 2019 | $55,081,000 | +27.5% | 4,798 | +46.0% | 0.00% | – |
| Q2 2019 | $43,211,000 | -53.3% | 3,286 | -46.3% | 0.00% | – |
| Q1 2019 | $92,596,000 | +59639.4% | 6,116 | +67855.6% | 0.00% | – |
| Q4 2018 | $155,000 | -98.9% | 9 | -99.1% | 0.00% | – |
| Q3 2018 | $14,239,000 | -52.6% | 966 | -23.3% | 0.00% | – |
| Q2 2018 | $30,051,000 | -77.9% | 1,260 | -76.3% | 0.00% | – |
| Q1 2018 | $135,696,000 | +30.4% | 5,311 | -5.8% | 0.00% | – |
| Q4 2017 | $104,077,000 | +377.7% | 5,638 | +171.4% | 0.00% | – |
| Q3 2017 | $21,788,000 | -20.5% | 2,077 | -5.2% | 0.00% | – |
| Q2 2017 | $27,409,000 | +11273.0% | 2,191 | +9029.2% | 0.00% | – |
| Q1 2017 | $241,000 | -98.2% | 24 | -97.2% | 0.00% | – |
| Q4 2016 | $13,530,000 | -23.2% | 869 | -5.0% | 0.00% | – |
| Q3 2016 | $17,623,000 | +180.6% | 915 | +72.6% | 0.00% | – |
| Q2 2016 | $6,281,000 | -83.7% | 530 | -62.1% | 0.00% | – |
| Q4 2015 | $38,446,000 | +26.2% | 1,398 | +1.5% | 0.00% | – |
| Q3 2015 | $30,468,000 | – | 1,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |